JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB263272

Human NARF (IOP2) knockout HeLa cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

NARF KO cell lysate available now. KO validated. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 16 bp deletion in exon3 and 1 bp deletion in exon3 and 5 bp deletion in exon3.
3 Images
Sanger Sequencing - Human NARF (IOP2) knockout HeLa cell lysate (AB263272)
  • Sanger seq

Unknown

Sanger Sequencing - Human NARF (IOP2) knockout HeLa cell lysate (AB263272)

Allele-1 : 16 bp deletion in exon3

Sanger Sequencing - Human NARF (IOP2) knockout HeLa cell lysate (AB263272)
  • Sanger seq

Unknown

Sanger Sequencing - Human NARF (IOP2) knockout HeLa cell lysate (AB263272)

Allele-3 : 1 bp deletion in exon3

Sanger Sequencing - Human NARF (IOP2) knockout HeLa cell lysate (AB263272)
  • Sanger seq

Unknown

Sanger Sequencing - Human NARF (IOP2) knockout HeLa cell lysate (AB263272)

Allele-2 : 5 bp deletion in exon3

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 16 bp deletion in exon3 and 1 bp deletion in exon3 and 5 bp deletion in exon3.

Disease

Adenocarcinoma

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab263272-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human NARF knockout HeLa cell lysate", "number":"AB263272-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HeLa cell lysate", "number":"AB263272-CMP02", "productcode":"" } ] } } }

Properties and storage information

Gene name
NARF
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

IOP2 also known by alternate names programmable cell death protein 6-interacting protein or PDCD6IP plays a role in cellular mechanisms involving vesicle trafficking and endocytosis. This protein approximately weighs 80 kDa and is widely expressed in various tissues including brain liver and heart. IOP2 exhibits interactions with other proteins within the cell enabling the formation of multitumor suppressor complexes that regulate cell survival and division.
Biological function summary

IOP2 functions in intracellular signaling and membrane dynamics. It participates as a component of the ESCRT (endosomal sorting complexes required for transport) machinery. In this context IOP2 facilitates the sorting of ubiquitinated transmembrane proteins into the internal vesicles of multivesicular bodies. Its activity in this complex highlights the regulation of down-regulating surface receptors and contributing to the cellular homeostasis.

Pathways

IOP2 interacts with mechanisms controlling cellular growth and apoptosis. One of the significant pathways includes the mitogen-activated protein kinase (MAPK) signaling which influences cell proliferation. Within this pathway IOP2 relates to proteins such as ERK1/2 playing a role in the signal transduction processes. Additionally the protein contributes to the regulation of PI3K/AKT pathway impacting cell survival through its interactions within the signaling network.

IOP2 exhibits connection to cancer and neurodegenerative disorders. In oncological contexts altered IOP2 expression links with esophageal squamous cell carcinoma suggesting a role in tumor progression. Additionally in neurodegenerative conditions IOP2 interaction with Alzheimer’s disease-related proteins like amyloid precursor protein (APP) reflects its involvement in pathological processes. Changes in IOP2 function or expression may therefore serve as potential biomarkers or targets for therapeutic intervention in these diseases.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com